Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Granotapide is a microsomal triglyceride transfer protein (MTP) inhibitor that treats and rather prevents atherosclerosis, coronary artery disease, metabolic syndrome, obesity, diabetes mellitus, prediabetes mellitus, and hypertension.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 210.00 | |
5 mg | In stock | $ 530.00 | |
10 mg | In stock | $ 766.00 | |
25 mg | In stock | $ 1,180.00 | |
50 mg | In stock | $ 1,590.00 | |
100 mg | In stock | $ 2,150.00 | |
500 mg | In stock | $ 4,290.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 778.00 |
Description | Granotapide is a microsomal triglyceride transfer protein (MTP) inhibitor that treats and rather prevents atherosclerosis, coronary artery disease, metabolic syndrome, obesity, diabetes mellitus, prediabetes mellitus, and hypertension. |
Molecular Weight | 718.71 |
Formula | C39H37F3N2O8 |
CAS No. | 594842-13-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 27.5 mg/mL (38.26 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Granotapide 594842-13-4 Metabolism CETP inhibitor inhibit